Literature DB >> 20546376

Hypothesis: it is time to reconsider phenotypes in hypertension.

Marcelo Orias1, Aldo H Tabares, Aldo J Peixoto.   

Abstract

The study of genes and mechanisms associated with hypertension is hampered by the heterogeneity of hypertensive patients. Refining the definition of hypertension is a potential means of improving the clarity of mechanistic studies, but the lack of intermediate phenotypes hinders the assessment of causal relationships. Looking at younger individuals and hemodynamic subsets of hypertension is one such refinement. The authors argue that the separate analysis of patients with isolated diastolic hypertension, predominantly diastolic hypertension, and isolated systolic hypertension in the young in combination with common biomarkers may be an initial step to decrease heterogeneity within patient subsets, thus providing new avenues for genetic and pathophysiological studies.

Entities:  

Mesh:

Year:  2010        PMID: 20546376      PMCID: PMC8673086          DOI: 10.1111/j.1751-7176.2010.00266.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  58 in total

1.  Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama study.

Authors:  A Hozawa; T Ohkubo; K Nagai; M Kikuya; M Matsubara; I Tsuji; S Ito; H Satoh; S Hisamichi; Y Imai
Journal:  Arch Intern Med       Date:  2000-11-27

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 3.  Selected major risk factors and global and regional burden of disease.

Authors:  Majid Ezzati; Alan D Lopez; Anthony Rodgers; Stephen Vander Hoorn; Christopher J L Murray
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

Review 4.  Mechanisms of sympathetic activation in obesity-related hypertension.

Authors:  Murray Esler; Nora Straznicky; Nina Eikelis; Kazuko Masuo; Gavin Lambert; Elisabeth Lambert
Journal:  Hypertension       Date:  2006-09-25       Impact factor: 10.190

Review 5.  Autonomic nervous cardiovascular regulation in borderline hypertension.

Authors:  S Julius; M Esler
Journal:  Am J Cardiol       Date:  1975-10-31       Impact factor: 2.778

6.  Isolated elevation of diastolic blood pressure. Real or artifactual?

Authors:  S G Blank; S J Mann; G D James; J E West; T G Pickering
Journal:  Hypertension       Date:  1995-09       Impact factor: 10.190

7.  Hemodynamic study of 85 patients with borderline hypertension.

Authors:  M E Safar; Y A Weiss; J A Levenson; G M London; P L Milliez
Journal:  Am J Cardiol       Date:  1973-03       Impact factor: 2.778

Review 8.  Haemodynamics in early essential hypertension--still an area of controversy.

Authors:  P Lund-Johansen
Journal:  J Hypertens       Date:  1983-10       Impact factor: 4.844

9.  Blood pressure categories, hypertensive subtypes, and the metabolic syndrome.

Authors:  Stanley S Franklin; Michael G Barboza; Jose R Pio; Nathan D Wong
Journal:  J Hypertens       Date:  2006-10       Impact factor: 4.844

10.  Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.

Authors:  Daniel I Feig; Beth Soletsky; Richard J Johnson
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

View more
  3 in total

1.  Reconsider hypertension phenotypes and osteoporosis.

Authors:  Charalampos Dokos; Christos Savopoulos; Apostolos Hatzitolios
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-17       Impact factor: 3.738

Review 2.  Is Isolated Diastolic Hypertension an Important Phenotype?

Authors:  Cesar A Romero; Aldo H Tabares; Marcelo Orias
Journal:  Curr Cardiol Rep       Date:  2021-10-16       Impact factor: 2.931

3.  Hypertension Subtypes among Hypertensive Patients in Ibadan.

Authors:  Abiodun M Adeoye; Adewole Adebiyi; Bamidele O Tayo; Babatunde L Salako; Adesola Ogunniyi; Richard S Cooper
Journal:  Int J Hypertens       Date:  2014-10-19       Impact factor: 2.420

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.